Cargando…
A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648526/ https://www.ncbi.nlm.nih.gov/pubmed/26407235 http://dx.doi.org/10.1038/bcj.2015.80 |
| _version_ | 1782401250741977088 |
|---|---|
| author | Papayannidis, C DeAngelo, D J Stock, W Huang, B Shaik, M N Cesari, R Zheng, X Reynolds, J M English, P A Ozeck, M Aster, J C Kuo, F Huang, D Lira, P D McLachlan, K R Kern, K A Garcia-Manero, G Martinelli, G |
| author_facet | Papayannidis, C DeAngelo, D J Stock, W Huang, B Shaik, M N Cesari, R Zheng, X Reynolds, J M English, P A Ozeck, M Aster, J C Kuo, F Huang, D Lira, P D McLachlan, K R Kern, K A Garcia-Manero, G Martinelli, G |
| author_sort | Papayannidis, C |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4648526 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46485262015-12-01 A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma Papayannidis, C DeAngelo, D J Stock, W Huang, B Shaik, M N Cesari, R Zheng, X Reynolds, J M English, P A Ozeck, M Aster, J C Kuo, F Huang, D Lira, P D McLachlan, K R Kern, K A Garcia-Manero, G Martinelli, G Blood Cancer J Letter to the Editor Nature Publishing Group 2015-09 2015-09-25 /pmc/articles/PMC4648526/ /pubmed/26407235 http://dx.doi.org/10.1038/bcj.2015.80 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Letter to the Editor Papayannidis, C DeAngelo, D J Stock, W Huang, B Shaik, M N Cesari, R Zheng, X Reynolds, J M English, P A Ozeck, M Aster, J C Kuo, F Huang, D Lira, P D McLachlan, K R Kern, K A Garcia-Manero, G Martinelli, G A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma |
| title | A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma |
| title_full | A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma |
| title_fullStr | A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma |
| title_full_unstemmed | A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma |
| title_short | A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma |
| title_sort | phase 1 study of the novel gamma-secretase inhibitor pf-03084014 in patients with t-cell acute lymphoblastic leukemia and t-cell lymphoblastic lymphoma |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648526/ https://www.ncbi.nlm.nih.gov/pubmed/26407235 http://dx.doi.org/10.1038/bcj.2015.80 |
| work_keys_str_mv | AT papayannidisc aphase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT deangelodj aphase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT stockw aphase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT huangb aphase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT shaikmn aphase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT cesarir aphase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT zhengx aphase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT reynoldsjm aphase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT englishpa aphase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT ozeckm aphase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT asterjc aphase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT kuof aphase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT huangd aphase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT lirapd aphase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT mclachlankr aphase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT kernka aphase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT garciamanerog aphase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT martinellig aphase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT papayannidisc phase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT deangelodj phase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT stockw phase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT huangb phase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT shaikmn phase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT cesarir phase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT zhengx phase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT reynoldsjm phase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT englishpa phase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT ozeckm phase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT asterjc phase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT kuof phase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT huangd phase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT lirapd phase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT mclachlankr phase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT kernka phase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT garciamanerog phase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma AT martinellig phase1studyofthenovelgammasecretaseinhibitorpf03084014inpatientswithtcellacutelymphoblasticleukemiaandtcelllymphoblasticlymphoma |